| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/31/2013 | CN101460462B Spirocyclic nitriles as protease inhibitors |
| 07/30/2013 | US8497377 Process for preparing pradofloxacin |
| 07/30/2013 | US8497376 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 07/30/2013 | US8497371 Pipemidic acid derivative autotaxin inhibitors |
| 07/30/2013 | US8497270 Macrocyclic integrase inhibitors |
| 07/30/2013 | US8497266 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2599611C Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 07/30/2013 | CA2583973C Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/25/2013 | WO2013109866A1 Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same |
| 07/25/2013 | WO2013109388A2 1,5-naphthyridine derivatives and melk inhibitors containing the same |
| 07/25/2013 | WO2013108809A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013107820A1 Novel fap inhibitors |
| 07/25/2013 | WO2013107326A1 NEW-TYPE IMIDAZO [1, 2-a] PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF |
| 07/25/2013 | WO2013080220A3 Process for preparation of 3-[2-[4-(6-fluro-1, 2-benzisoxazol-3-yl)-1-piperidtnyl]ethyl]-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyriodo[1, 2-a]pyrimidin-4-one |
| 07/25/2013 | US20130190499 Azaisoquinolinone derivatives as NK3 antagonists |
| 07/25/2013 | US20130190498 Isatin derivatives, medicaments containing the isatin derivatives and method for its preparation |
| 07/25/2013 | US20130190496 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors |
| 07/25/2013 | US20130190492 Substituted quinazoline and pyrido-pyrimidine derivatives |
| 07/25/2013 | US20130190351 Bicyclic amides for enhancing glutamatergic synaptic responses |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130190347 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof |
| 07/25/2013 | US20130190345 Matrinic acid/matrine derivatives and preparation methods and uses thereof |
| 07/25/2013 | US20130190344 Pyrido[4,3-b]indoles and methods of use |
| 07/25/2013 | US20130190339 Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190332 Substituted Imidazo[1,2-a]pyrimidines and -pyridines |
| 07/25/2013 | US20130190331 Pyrido[4,3-b]indoles and methods of use |
| 07/25/2013 | US20130190328 Pyrido[4,3-b]indoles and methods of use |
| 07/25/2013 | US20130190323 Pyrido[3,4-b]indoles and methods of use |
| 07/25/2013 | US20130190322 Pyrido[4,3-b]indoles containing rigid moieties |
| 07/25/2013 | US20130190316 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| 07/25/2013 | US20130190315 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| 07/25/2013 | US20130190308 Pyrido[3,4-b]indoles and methods of use |
| 07/25/2013 | US20130190306 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/25/2013 | US20130190304 Tetracyclic compounds |
| 07/25/2013 | US20130190303 Bridged heterocyclic compounds and methods of use |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190294 Compounds and methods for treating diabetes |
| 07/25/2013 | US20130190293 Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| 07/25/2013 | US20130190288 Benzyl sulfonamide derivatives as rorc modulators |
| 07/25/2013 | US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds |
| 07/25/2013 | US20130187136 Synthesis of aza-acenes as novel n-type materials for organic electronics |
| 07/25/2013 | CA2857346A1 1,5-naphthyridine derivatives and melk inhibitors containing the same |
| 07/25/2013 | CA2854093A1 3,5-disubstituted alkynylbenzene compound and salt thereof |
| 07/24/2013 | EP2617722A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/24/2013 | EP2617721A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
| 07/24/2013 | EP2617717A1 P2x4 receptor antagonist |
| 07/24/2013 | EP2617419A1 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 07/24/2013 | EP2616469A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | EP2616468A1 Fused heteroaryls and their uses |
| 07/24/2013 | EP2616467A1 Substituted azaindoles |
| 07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
| 07/24/2013 | EP2616443A1 Phtalazine derivatives as jak1 inhibitors |
| 07/24/2013 | EP2615916A1 Fused pyrazole derivatives as novel erk inhibitors |
| 07/24/2013 | CN1795196B Use of amide in preparing compound agent for repairing corneal sensitivity |
| 07/24/2013 | CN103221412A (Aza)indolizine derivative and pharmaceutical use thereof |
| 07/24/2013 | CN103221409A Herbicidal benzoxazinones |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221403A Heterocyclic compounds and their uses |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103214486A Beta-carboline derivative or medicinal salt as well as preparation method and anti-tumour application thereof |
| 07/24/2013 | CN103214485A Method suitable for industrial production of high-purity 9-hydroxy-risperidone |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214482A Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 07/24/2013 | CN103214481A Novel imidazo[1,2-a]pyridines compound, preparation method, pharmaceutical composition containing imidazo[1,2-a]pyridines compound and application |
| 07/24/2013 | CN103214480A Pyrazolopyridines alkynylbenzene compound and medicinal composition and application |
| 07/24/2013 | CN103214479A Pyrazole naphthylurea tyrosine kinase inhibitor and its application |
| 07/24/2013 | CN103214478A Pyridineoxopyridazine derivatives |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214337A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101885722B Heterocycle alkyne and benzene compound, medicinal composition and application thereof |
| 07/24/2013 | CN101817787B Androgen receptor antagonist for resisting prostate cancer |
| 07/24/2013 | CN101792422B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101778847B Crystalline pyridazine compound |
| 07/24/2013 | CN101691367B Piperazine and <2,1-a> isoquinoline compounds with antifungal activity and salts thereof |
| 07/24/2013 | CN101668760B Aminopyrimidines useful as inhibitors of protein kinases |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/24/2013 | CN101570504B Novel compounds for electronic material and organic electronic device using the same |
| 07/24/2013 | CN101560186B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN101511830B Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine |
| 07/24/2013 | CN101283071B Compositions containing fluorine substituted olefins |
| 07/24/2013 | CN101248153B Foaming agents and composition containing fluorine substituted olefins, and foaming method |
| 07/24/2013 | CN101243087B 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them |
| 07/24/2013 | CN101212903B Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/24/2013 | CN101203518B Novel fluorene derivatives, composition containing said derivatives and the use thereof |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492547 Method for the enrichment of buprenorphine using chromatographic techniques |
| 07/23/2013 | US8492377 MTKI quinazoline derivatives |
| 07/23/2013 | CA2545261C Piperidine-substituted indoles- or heteroderivatives thereof |
| 07/18/2013 | WO2013106614A1 Triazolyl-substituted pyridyl compounds useful as kinase inhibitors |
| 07/18/2013 | WO2013106612A1 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors |
| 07/18/2013 | WO2013106460A2 Compositions and methods for treating malignant astrocytomas |
| 07/18/2013 | WO2013105909A1 Use of curvularin and analcime in the production of a fungicide, composition and method for producing the latter (alternatives) |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105206A1 Material for organic electroluminescent element, and element using same |
| 07/18/2013 | WO2013105066A1 Salts of an ip receptor agonist |
| 07/18/2013 | WO2013105065A1 Fused piperidines as ip receptor agonists for the treatment of pah and related disorders |
| 07/18/2013 | WO2013105063A1 Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |